Can Urethral Bulking Agents Salvage Failed Slings?

Area of Science:

• Urology
• Female Pelvic Medicine
• Reconstructive Surgery

Background:

• Stress urinary incontinence (SUI) is a common condition affecting many women.
• Sling surgery is a frequent treatment for SUI, but can fail in a significant number of cases.
• Alternative or adjunctive treatments are needed for persistent SUI post-sling.

Purpose of the Study:

• To evaluate the efficacy of urethral bulking agents for SUI in patients with prior failed sling surgery.
• To assess patient-reported outcomes and validated questionnaire scores following bulking agent injections.
• To determine the durability of symptom improvement over time.

Main Methods:

• Retrospective review of 73 patients with SUI post-failed sling surgery.
• Urethral bulking agents (Macroplastique or collagen) were administered.
• Outcomes included patient-reported improvement, need for further interventions, and validated questionnaires (AUA SI, MII).

Main Results:

• 71% of patients reported at least partial symptom resolution at short-term follow-up.
• Significant improvements were noted in validated questionnaire scores (AUA SI, MII) at short-term follow-up.
• Long-term follow-up (mean 39.6 months) in 40 patients showed persistent statistically significant improvement in SUI and quality of life domains.

Conclusions:

• Urethral bulking agents provide short-term symptom improvement or resolution in 71% of patients with persistent SUI after sling procedures.
• SUI-specific improvement persists for an average of 35 months in patients with available long-term data.
• Bulking agents represent a viable treatment option for recurrent SUI following sling failure.